METTL14 aggravates podocyte injury and glomerulopathy progression through N6-methyladenosine-dependent downregulating of Sirt1
Zhihui Lu(Fudan University), Xiaoqiang Ding(Fudan University), Yan Dai(Fudan University), Nana Song(Shanghai Medical College of Fudan University), Jiachang Hu(Fudan University), Jing Chen(Shaanxi Provincial Hospital of Traditional Chinese Medicine), Hong Liu(Fudan University), Jie Teng(Sun Yat-sen University), Yichun Ning(Fudan University), Jiaming Zhu(Second Affiliated Hospital of Jilin University), Jianzhou Zou(Fudan University), Yiran Liang(Qilu Hospital of Shandong University), Yi Fang(Shanghai Medical College of Fudan University)
Cited by 115
Related Papers
Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets
|Seminars in Cancer Biology|2019|1k
circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer
|Molecular Therapy|2019|513
RETRACTED ARTICLE: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis
|Molecular Cancer|2020|396
LncRNA–CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA‐215
|Journal of Cellular Physiology|2018|301
Ultrasensitive single-cell proteomics workflow identifies >1000 protein groups per mammalian cell
|Chemical Science|2020|245